Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Morphine + fentanyl is a combination of two opioid analgesics, morphine and fentanyl, used together for the management of severe pain, typically in surgical or critical care settings. Both drugs act as agonists at the mu-opioid receptor in the central nervous system, leading to potent analgesic effects. Morphine is a naturally occurring opiate derived from the opium poppy and has been widely used for pain relief. Fentanyl is a synthetic opioid that is 50–100 times more potent than morphine and provides rapid onset and short duration of action[1][2][4]. The combination may be employed when enhanced or synergistic pain control is required, but it carries an increased risk of respiratory depression and other opioid-related adverse effects due to their additive pharmacological actions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morphine + fentanyl.